DRY EYE DISEASE – RISK FACTORS, PATHOGENESIS, DIAGNOSTIC METHODS, CLINICAL MANIFESTATIONS AND TREATMENT – NEW LITERATURE REPORTS

Keywords: Dry Eye, EDE, ADDE, Artificial Tears, Dry Eye Diagnosis, Dry Eye Syndrome Treatment

Abstract

Dry eye syndrome (DED) is a prevalent condition, affecting millions of people worldwide.         The condition is characterised by a multifactorial disorder of the ocular surface, resulting in the loss of the natural protective barrier of the eyes, known as the tear film, and accompanied by more or less characteristic symptoms. The objective of this article is to present a thorough review of the extant scientific literature, incorporating an exhaustive analysis of the pathogenesis, identification of risk factors, and discussion of diagnostic and therapeutic methods, with consideration given to both conventional approaches and the most recent research findings. Despite ongoing research, the etiology of dry eye syndrome remains unclear. However, various factors have been identified as potential risk elements, including age, gender, environmental influences, ethnics origin, and comorbidities, particularly autoimmune diseases. Tear substitutes remain the primary and most commonly used treatment method, but recent scientific research has focused on drugs that are capable of modifying inflammatory processes to a much greater extent. Lifestyle modifications or the use of increasingly available specialised medications have enabled patients to recover. The condition of dry eye syndrome poses significant challenges in the domains of both ophthalmology and numerous other medical specialties. The effective control of the disease will only be possible with a coordinated approach to the following: symptoms, pathogenesis and patient capabilities. Further research into mechanisms and diagnostic methods is imperative, with the potential to significantly improve the quality of life for millions of patients.

References

Zemanová M. (2021). DRY EYE DISEASE. A REVIEW. SYNDROM SUCHÉHO OKA. přehled. Ceska a slovenska oftalmologie: casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti, 77(3), 107–119. https://doi.org/10.31348/2020/29

Sheppard, J., Shen Lee, B., & Periman, L. M. (2023). Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists. Annals of medicine, 55(1), 241–252. https://doi.org/10.1080/07853890.2022.2157477

Britten-Jones, A. C., Wang, M. T. M., Samuels, I., Jennings, C., Stapleton, F., & Craig, J. P. (2024). Epidemiology and Risk Factors of Dry Eye Disease: Considerations for Clinical Management. Medicina (Kaunas, Lithuania), 60(9), 1458. https://doi.org/10.3390/medicina60091458

McCann, P., Abraham, A. G., Mukhopadhyay, A., Panagiotopoulou, K., Chen, H., Rittiphairoj, T., Gregory, D. G., Hauswirth, S. G., Ifantides, C., Qureshi, R., Liu, S. H., Saldanha, I. J., & Li, T. (2022). Prevalence and Incidence of Dry Eye and Meibomian Gland Dysfunction in the United States: A Systematic Review and Meta-analysis. JAMA ophthalmology, 140(12), 1181–1192. https://doi.org/10.1001/jamaophthalmol.2022.4394

Barabino S. (2022). Is dry eye disease the same in young and old patients? A narrative review of the literature. BMC ophthalmology, 22(1), 85. https://doi.org/10.1186/s12886-022-02269-2

Kwon, J., Moghtader, A., Kang, C., Bibak Bejandi, Z., Shahjahan, S., Alzein, A. i Djalilian, AR (2025). Przegląd choroby suchego oka dla lekarzy podstawowej opieki zdrowotnej. Medicina (Kowno, Litwa), 61 (3), 460. https://doi.org/10.3390/medicina61030460

Qian, L., & Wei, W. (2022). Identified risk factors for dry eye syndrome: A systematic review and meta-analysis. PloS one, 17(8), e0271267. https://doi.org/10.1371/journal.pone.0271267

Doctor, M. B., & Basu, S. (2022). Lacrimal Gland Insufficiency in Aqueous Deficiency Dry Eye Disease: Recent Advances in Pathogenesis, Diagnosis, and Treatment. Seminars in ophthalmology, 37(7-8), 801–812. https://doi.org/10.1080/08820538.2022.2075706

Talens-Estarelles, C., García-Marqués, J. V., Cerviño, A., & García-Lázaro, S. (2022). Dry Eye-Related Risk Factors for Digital Eye Strain. Eye & contact lens, 48(10), 410–415. https://doi.org/10.1097/ICL.0000000000000923

Mangoli, M. V., Bubanale, S. C., Bhagyajyothi, B. K., & Goyal, D. (2023). Dry eye disease in diabetics versus non-diabetics: Associating dry eye severity with diabetic retinopathy and corneal nerve sensitivity. Indian journal of ophthalmology, 71(4), 1533–1537. https://doi.org/10.4103/IJO.IJO_2680_22

Katipoğlu, Z., & Abay, R. N. (2023). The relationship between dry eye disease and anticholinergic burden. Eye (London, England), 37(14), 2921–2925. https://doi.org/10.1038/s41433-023-02442-x

Golden, M. I., Meyer, J. J., Zeppieri, M., & Patel, B. C. (2024). Dry Eye Syndrome. In StatPearls. StatPearls Publishing.

Gorimanipalli, B., Khamar, P., Sethu, S., & Shetty, R. (2023). Hormones and dry eye disease. Indian journal of ophthalmology, 71(4), 1276–1284. https://doi.org/10.4103/IJO.IJO_2887_22

Vidal-Rohr, M., Craig, JP, Davies, LN i Wolffsohn, JS (2024). Klasyfikacja podtypów zespołu suchego oka. Soczewki kontaktowe i przedni odcinek oka: czasopismo Brytyjskiego Stowarzyszenia Soczewek Kontaktowych, 47 (5), 102257. https://doi.org/10.1016/j.clae.2024.102257

Rolando, M., & Barabino, S. (2023). Dry Eye Disease: What Is the Role of Vitamin D? . International journal of molecular sciences, 24(2), 1458. https://doi.org/10.3390/ijms24021458

Wang, HH, Chen, WY, Huang, YH, Hsu, SM, Tsao, YP, Hsu, YH i Chang, MS (2022). Interleukina-20 jest związana z zespołem suchego oka i stanowi potencjalny cel terapeutyczny. Journal of biomedical science, 29 (1), 36. https://doi.org/10.1186/s12929-022-00821-2

McMonnies CW (2021). Dlaczego objawy i obiektywne oznaki zespołu suchego oka mogą nie być ze sobą powiązane. Journal of optometry, 14 (1), 3–10. https://doi.org/10.1016/j.optom.2020.10.002

Barabino, S. i Benítez-Del-Castillo, JM (2024). Patogeneza i objawy kliniczne zespołu suchego oka: poszukiwanie korelacji w praktyce klinicznej. European Review for Medical and Pharmacological Sciences, 28 (5), 1881–1890. https://doi.org/10.26355/eurrev_202403_35602

Yan Z. P. (2020). Dry eye symptoms and signs in children wearing OK lenses for six months in China. Journal francais d'ophtalmologie, 43(3), 211–215. https://doi.org/10.1016/j.jfo.2019.07.029

Stapleton, F., Velez, F. G., Lau, C., & Wolffsohn, J. S. (2024). Dry eye disease in the young: A narrative review. The ocular surface, 31, 11–20. https://doi.org/10.1016/j.jtos.2023.12.001

Yu, K., Bunya, V., Maguire, M., Asbell, P., Ying, G. S., & Dry Eye Assessment and Management Study Research Group (2021). Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study. Ophthalmology, 128(10), 1384–1392. https://doi.org/10.1016/j.ophtha.2021.03.030

Khoo, P., Groeneveld, T., Boyle, F., O'Neill, S., Forster, B., & Watson, S. L. (2022). Dry eye signs and symptoms in patients on aromatase inhibitor therapy. Eye (London, England), 36(4), 766–772. https://doi.org/10.1038/s41433-021-01538-6

Bjordal, O., Norheim, K. B., Rødahl, E., Jonsson, R., & Omdal, R. (2020). Primary Sjögren's syndrome and the eye. Survey of ophthalmology, 65(2), 119–132. https://doi.org/10.1016/j.survophthal.2019.10.004

Narang, P., Donthineni, P. R., D'Souza, S., & Basu, S. (2023). Evaporative dry eye disease due to meibomian gland dysfunction: Preferred practice pattern guidelines for diagnosis and treatment. Indian journal of ophthalmology, 71(4), 1348–1356. https://doi.org/10.4103/IJO.IJO_2841_22

Wolffsohn, J. S., Travé-Huarte, S., Stapleton, F., Downie, L. E., Schulze, M. M., Guthrie, S., Stahl, U., Wang, M. T. M., & Craig, J. P. (2025). Relative importance of tear homeostatic signs for the diagnosis of dry eye disease. The ocular surface, 36, 151–155. https://doi.org/10.1016/j.jtos.2025.01.010

Mohamed, H. B., Abd El-Hamid, B. N., Fathalla, D., & Fouad, E. A. (2022). Current trends in pharmaceutical treatment of dry eye disease: A review. European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences, 175, 106206. https://doi.org/10.1016/j.ejps.2022.106206

Barabino, S., Benitez-Del-Castillo, J. M., Fuchsluger, T., Labetoulle, M., Malachkova, N., Meloni, M., Utheim, T. P., & Rolando, M. (2020). Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification. European review for medical and pharmacological sciences, 24(17), 8642–8652. https://doi.org/10.26355/eurrev_202009_22801

Periman, LM, Perez, VL, Saban, DR, Lin, MC i Neri, P. (2020). Podstawy immunologiczne zespołu suchego oka i aktualne opcje leczenia miejscowego. Journal of ocular pharmacology and therapeutics: oficjalne czasopismo Association for Ocular Pharmacology and Therapeutics, 36 (3), 137–146. https://doi.org/10.1089/jop.2019.0060

Mittal, R., Patel, S., & Galor, A. (2021). Alternative therapies for dry eye disease. Current opinion in ophthalmology, 32(4), 348–361. https://doi.org/10.1097/ICU.0000000000000768

Rolando, M., & Merayo-Lloves, J. (2022). Management Strategies for Evaporative Dry Eye Disease and Future Perspective. Current eye research, 47(6), 813–823. https://doi.org/10.1080/02713683.2022.2039205

Vazirani, J., Sridhar, U., Gokhale, N., Doddigarla, V. R., Sharma, S., & Basu, S. (2023). Autologous serum eye drops in dry eye disease: Preferred practice pattern guidelines. Indian journal of ophthalmology, 71(4), 1357–1363. https://doi.org/10.4103/IJO.IJO_2756_22

Kumar, N. R., Praveen, M., Narasimhan, R., Khamar, P., D'Souza, S., Sinha-Roy, A., Sethu, S., Shetty, R., & Ghosh, A. (2023). Tear biomarkers in dry eye disease: Progress in the last decade. Indian journal of ophthalmology, 71(4), 1190–1202. https://doi.org/10.4103/IJO.IJO_2981_22

Yang, Y. J., Lee, W. Y., Kim, Y. J., & Hong, Y. P. (2021). A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome. International journal of environmental research and public health, 18(5), 2383. https://doi.org/10.3390/ijerph18052383

Paik, B., & Tong, L. (2022). Topical Omega-3 Fatty Acids Eyedrops in the Treatment of Dry Eye and Ocular Surface Disease: A Systematic Review. International journal of molecular sciences, 23(21), 13156. https://doi.org/10.3390/ijms232113156

Aragona, P., Giannaccare, G., Mencucci, R., Rubino, P., Cantera, E., & Rolando, M. (2021). Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review. The British journal of ophthalmology, 105(4), 446–453. https://doi.org/10.1136/bjophthalmol-2019-315747

McCann, P., Kruoch, Z., Lopez, S., Malli, S., Qureshi, R., & Li, T. (2024). Interventions for Dry Eye: An Overview of Systematic Reviews. JAMA ophthalmology, 142(1), 58–74. https://doi.org/10.1001/jamaophthalmol.2023.5751

Ren, X., Chou, Y., Wang, Y., Chen, Y., Liu, Z., & Li, X. (2021). Comparison of intense pulsed light and near-infrared light in the treatment of dry eye disease: a prospective randomized study. Acta ophthalmologica, 99(8), e1307–e1314. https://doi.org/10.1111/aos.14833

Huang, R., Su, C., Fang, L., Lu, J., Chen, J., & Ding, Y. (2022). Dry eye syndrome: comprehensive etiologies and recent clinical trials. International ophthalmology, 42(10), 3253–3272. https://doi.org/10.1007/s10792-022-02320-7

Chatterjee, S., Agrawal, D., Sanowar, G., & Kandoi, R. (2021). Prevalence of symptoms of dry eye disease in an urban Indian population. Indian journal of ophthalmology, 69(5), 1061–1066. https://doi.org/10.4103/ijo.IJO_1796_20

Kunboon, A., Tananuvat, N., Upaphong, P., Wongpakaran, N., & Wongpakaran, T. (2024). Prevalence of dry eye disease symptoms, associated factors and impact on quality of life among medical students during the pandemic. Scientific reports, 14(1), 23986. https://doi.org/10.1038/s41598-024-75345-w

Kaur, K., Gurnani, B., Nayak, S., Deori, N., Kaur, S., Jethani, J., Singh, D., Agarkar, S., Hussaindeen, J. R., Sukhija, J., & Mishra, D. (2022). Digital Eye Strain- A Comprehensive Review. Ophthalmology and therapy, 11(5), 1655–1680. https://doi.org/10.1007/s40123-022-00540-9

Britten-Jones, A. C., Wang, M. T. M., Samuels, I., Jennings, C., Stapleton, F., & Craig, J. P. (2024). Epidemiology and Risk Factors of Dry Eye Disease: Considerations for Clinical Management. Medicina (Kaunas, Lithuania), 60(9), 1458. https://doi.org/10.3390/medicina60091458

Ozcan, A. A., Ulas, B., & Ciloglu, E. (2022). Tarsorrhaphy with Sutureless Amnion Transplantation: Practical Management of Ocular Surface Pathologies. Beyoglu eye journal, 7(4), 313–319. https://doi.org/10.14744/bej.2022.10327

Nguyen, A., Kolluru, A., & Beglarian, T. (2023). Dry eye disease: A review of anti-inflammatory therapies. Taiwan journal of ophthalmology, 13(1), 3–12. https://doi.org/10.4103/2211-5056.369606

Views:

98

Downloads:

46

Published
2025-08-27
Citations
How to Cite
Bartłomiej Trzciński, Patryk Kowalczyk, Oliwia Gugała, Igor Winogrodzki, Alicja Stryczek-Schlusche, Aleksandra Magdalena Furczyńska, Wiktoria Socha, Aleksandra Gęsińska, Hanna Paszkiewicz, & Kamil Nowak. (2025). DRY EYE DISEASE – RISK FACTORS, PATHOGENESIS, DIAGNOSTIC METHODS, CLINICAL MANIFESTATIONS AND TREATMENT – NEW LITERATURE REPORTS. International Journal of Innovative Technologies in Social Science, 2(3(47). https://doi.org/10.31435/ijitss.3(47).2025.3583

Most read articles by the same author(s)